title: Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNFα monoclonal antibodies.
authors.forename: Srilakshmi M
authors.initials: SM
authors.lastname: Sharma
authors.forename: Tammy M
authors.initials: TM
authors.lastname: Martin
authors.forename: Carlos D
authors.initials: CD
authors.lastname: Rosé
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Dick
authors.forename: Athimalaipet V
authors.initials: AV
authors.lastname: Ramanan
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001168:Arthritis; D002648:Child; D003389:Cranial Nerve Diseases / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D003937:Diagnosis, Differential; D009877:Endophthalmitis / Q000175:diagnosis* / Q000209:etiology* / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D000069285:Infliximab; D008297:Male; D009154:Mutation / Q000235:genetics; D009169:Mycobacterium tuberculosis; D053473:Nod2 Signaling Adaptor Protein / Q000235:genetics; D012507:Sarcoidosis; D013585:Synovitis / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome; D014392:Tuberculosis, Ocular / Q000175:diagnosis* / Q000276:immunology / Q000382:microbiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014605:Uveitis / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D056660:Hereditary Autoinflammatory Diseases
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000995:Antitubercular Agents; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab